Nidal embolization of brain arteriovenous malformations: rates of cure, partial embolization, and clinical outcome

Clinical article

View More View Less
  • 1 Departments of Neurology,
  • 2 Radiology, and
  • 3 Neurosurgery, Bernard and Irene Schwartz Neurointerventional Service, New York University Langone Medical Center, New York, New York; and
  • 4 Department of Radiology, Hospital de Bellvitge, Barcelona, Spain
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object

Nidal embolization of brain arteriovenous malformations (bAVMs) has become an increasingly important component of bAVM treatment. However, controversy exists as to the relative efficacy and safety of single-stage versus multistage approaches to bAVM embolization, with recent literature favoring multistage strategies. The authors present a series of consecutive bAVMs embolized at their institution, demonstrating the safety and efficacy of a predominantly single-stage embolization strategy. The safety and efficacy of embolization are reported in the context of predetermined treatment strategies to provide more generalizable insight into treatment outcome.

Methods

One hundred thirty consecutive patients with 131 bAVMs underwent endovascular embolization at a single center. Diagnostic angiography with superselective microcatheterizations was performed in all patients. Postembolization angiograms were reviewed by 3 neuroradiologists for degree of occlusion and angiographic evidence of procedural complications. Patients were divided into cohorts based on the prospectively determined treatment strategy, which included the following: global devascularization of the bAVM (Devasc); targeting of a focal angioarchitectural weakness (Target), typically as an adjunct to surgery or Gamma Knife treatment; and primary occlusion of the bAVM by embolization alone (Occlude). Safety and efficacy were evaluated in the context of these treatment groups.

Results

The 131 bAVMs were treated over an average of 1.28 embolization sessions per bAVM; 105 bAVMs (80%) were treated in a single stage. The average percentage devascularization in the Devasc arm was 85.3%, which was statistically significantly greater than the 72% aggregate devascularization reported in 8 modern N-butyl cyanoacrylate and Onyx papers based on 1-sample Wilcoxon rank-sum testing (p < 0.001). Focal angioarchitectural weaknesses were successfully embolized for all 24 bAVMs in the Target group, directly with the embolic agent in 23 bAVMs and indirectly in 1 bAVM with a venous aneurysm/pseudoaneurysm by reducing arterial inflow and inducing venous thrombosis. Lesions in all patients in the Occlude arm were 100% occluded with embolization alone. Overall, the bAVMs in the Occlude arm were significantly smaller and required embolization of fewer pedicles than those in the Devasc group. One patient (0.8%) experienced significant morbidity following embolization, and 1 patient in the cohort died (0.8%).

Conclusions

This research communicates the authors' experience in developing a largely single-stage strategy for embolization of bAVMs. The results suggest that an aggressive, single-stage embolization may be implemented with a margin of safety and effectiveness similar to the multistage approaches more commonly reported in the literature. This work additionally introduces the importance of prospective assignment to a treatment strategy in assessing procedural outcome in bAVM embolization, thereby improving generalizability of the results and allowing for more rigorous interpretation of efficacy and safety.

Abbreviations used in this paper:bAVM = brain arteriovenous malformation; GKS = Gamma Knife surgery; LSA = lenticulostriate artery; MCA = middle cerebral artery; mRS = modified Rankin Scale; NBCA = N-butyl cyanoacrylate; PCA = posterior cerebral artery; S-M = Spetzler-Martin.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: Peter Kim Nelson, M.D., Department of Radiology, New York University Langone Medical Center, 560 First Avenue, Room HE-208, New York, New York 10016. email: nelsop01@med.nyu.edu.

Please include this information when citing this paper: published online April 27, 2012; DOI: 10.3171/2012.3.JNS111405.

  • 1

    Atkinson RP, , Awad IA, , Batjer HH, , Dowd CF, , Furlan A, & Giannotta SL, : Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke 32:14301442, 2001

    • Search Google Scholar
    • Export Citation
  • 2

    Choi JH, & Mohr JP: Brain arteriovenous malformations in adults. Lancet Neurol 4:299308, 2005

  • 3

    Debrun GM, , Aletich V, , Ausman JI, , Charbel F, & Dujovny M: Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 40:112121, 1997

    • Search Google Scholar
    • Export Citation
  • 4

    Fournier D, , TerBrugge KG, , Willinsky R, , Lasjaunias P, & Montanera W: Endovascular treatment of intracerebral arteriovenous malformations: experience in 49 cases. J Neurosurg 75:228233, 1991

    • Search Google Scholar
    • Export Citation
  • 5

    Fults D, & Kelly DL Jr: Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery 15:658662, 1984

  • 6

    Hamilton MG, & Spetzler RF: The prospective application of a grading system for arteriovenous malformations. Neurosurgery 34:27, 1994

  • 7

    Hartmann A, , Pile-Spellman J, , Stapf C, , Sciacca RR, , Faulstich A, & Mohr JP, : Risk of endovascular treatment of brain arteriovenous malformations. Stroke 33:18161820, 2002

    • Search Google Scholar
    • Export Citation
  • 8

    Haw CS, , terBrugge K, , Willinsky R, & Tomlinson G: Complications of embolization of arteriovenous malformations of the brain. J Neurosurg 104:226232, 2006

    • Search Google Scholar
    • Export Citation
  • 9

    Jayaraman MV, , Marcellus ML, , Hamilton S, , Do HM, , Campbell D, & Chang SD, : Neurologic complications of arteriovenous malformation embolization using liquid embolic agents. AJNR Am J Neuroradiol 29:242246, 2008

    • Search Google Scholar
    • Export Citation
  • 10

    Katsaridis V, , Papagiannaki C, & Aimar E: Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 50:589597, 2008

    • Search Google Scholar
    • Export Citation
  • 11

    Ledezma CJ, , Hoh BL, , Carter BS, , Pryor JC, , Putman CM, & Ogilvy CS: Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery 58:602611, 2006

    • Search Google Scholar
    • Export Citation
  • 12

    Meisel HJ, , Mansmann U, , Alvarez H, , Rodesch G, , Brock M, & Lasjaunias P: Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir (Wien) 144:879888, 2002

    • Search Google Scholar
    • Export Citation
  • 13

    Mounayer C, , Hammami N, , Piotin M, , Spelle L, , Benndorf G, & Kessler I, : Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 28:518523, 2007

    • Search Google Scholar
    • Export Citation
  • 14

    n-BCA Trial Investigators: N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 23:748755, 2002

    • Search Google Scholar
    • Export Citation
  • 15

    Ondra SL, , Troupp H, , George ED, & Schwab K: The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 73:387391, 1990

    • Search Google Scholar
    • Export Citation
  • 16

    Panagiotopoulos V, , Gizewski E, , Asgari S, , Regel J, , Forsting M, & Wanke I: Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 30:99106, 2009

    • Search Google Scholar
    • Export Citation
  • 17

    Pérez-Higueras A, , López RR, & Tapia DQ: Endovascular treatment of cerebral AVM: our experience with Onyx. Interv Neuroradiol 11:Suppl 1 141157, 2005

    • Search Google Scholar
    • Export Citation
  • 18

    Pierot L, , Januel AC, , Herbreteau D, , Barreau X, , Drouineau J, & Berge J, : Endovascular treatment of brain arteriovenous malformations using onyx: preliminary results of a prospective multicenter study. Interv Neuroradiol 11:Suppl 1 159164, 2005

    • Search Google Scholar
    • Export Citation
  • 19

    Spetzler RF, & Martin NA: A proposed grading system for arteriovenous malformations. J Neurosurg 65:476483, 1986

  • 20

    Starke RM, , Komotar RJ, , Otten ML, , Hahn DK, , Fischer LE, & Hwang BY, : Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits. Stroke 40:27832790, 2009

    • Search Google Scholar
    • Export Citation
  • 21

    Stefani MA, , Porter PJ, , terBrugge KG, , Montanera W, , Willinsky RA, & Wallace MC: Angioarchitectural factors present in brain arteriovenous malformations associated with hemorrhagic presentation. Stroke 33:920924, 2002

    • Search Google Scholar
    • Export Citation
  • 22

    Taylor CL, , Dutton K, , Rappard G, , Pride GL, , Replogle R, & Purdy PD, : Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg 100:810812, 2004

    • Search Google Scholar
    • Export Citation
  • 23

    Turjman F, , Massoud TF, , Viñuela F, , Sayre JW, , Guglielmi G, & Duckwiler G: Correlation of the angioarchitectural features of cerebral arteriovenous malformations with clinical presentation of hemorrhage. Neurosurgery 37:856862, 1995

    • Search Google Scholar
    • Export Citation
  • 24

    van Rooij WJ, , Sluzewski M, & Beute GN: Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 28:172178, 2007

  • 25

    Weber W, , Kis B, , Siekmann R, & Kuehne D: Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects. AJNR Am J Neuroradiol 28:371377, 2007

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 462 230 11
Full Text Views 201 26 0
PDF Downloads 125 20 0
EPUB Downloads 0 0 0